Nelson Cabatuan's Net Worth
$32 Thousand
Who is Nelson Cabatuan?
Nelson Cabatuan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RIGEL PHARMACEUTICALS INC, Rain Therapeutics Inc., and Lexaria Bioscience Corp..
SEC CIK
Nelson Cabatuan's CIK is 0001725908
Past Insider Trading and Trends
2018 was Nelson Cabatuan's most active year for acquiring shares with 2 total transactions. Nelson Cabatuan's most active month to acquire stocks was the month of December. 2018 was Nelson Cabatuan's most active year for disposing of shares, totalling 1 transactions. Nelson Cabatuan's most active month to dispose stocks was the month of September. 2020 saw Nelson Cabatuan paying a total of $0.00 for 110,000 shares, this is the most they've acquired in one year. In 2018 Nelson Cabatuan cashed out on 10,000 shares for a total of $31,200.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32
VP,Finance & Princ.Acctg. Off.Nelson Cabatuan owns 58 units of Common Stock which is worth $772.56. From 2017 to 2019 Nelson Cabatuan disposed a total of 10,000 shares of RIGEL PHARMACEUTICALS INC equalling to $31,200.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| -99.42% | -10.00K |
$3.12 | -$31,200.00 | 58 |
Scheduled
|
Oct 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rain Therapeutics Inc. (RAIN) No price found
VP Finance & Admin
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lexaria Bioscience Corp. (LEXX) Snapshot price: $3.26
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||